{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:06:57Z","timestamp":1768550817234,"version":"3.49.0"},"reference-count":268,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"abstract":"<jats:p>Despite a century of control and eradication campaigns, malaria remains one of the world's most devastating diseases. Our once-powerful therapeutic weapons are losing the war against the Plasmodium parasite, whose ability to rapidly develop and spread drug resistance hamper past and present malaria-control efforts. Finding new and effective treatments for malaria is now a top global health priority, fuelling an increase in funding and promoting open-source collaborations between researchers and pharmaceutical consortia around the world. The result of this is rapid advances in drug discovery approaches and technologies, with three major methods for antimalarial drug development emerging: (i) chemistry-based, (ii) target-based, and (iii) cell-based. Common to all three of these approaches is the unique ability of structural biology to inform and accelerate drug development. Where possible, SBDD (structure-based drug discovery) is a foundation for antimalarial drug development programmes, and has been invaluable to the development of a number of current pre-clinical and clinical candidates. However, as we expand our understanding of the malarial life cycle and mechanisms of resistance development, SBDD as a field must continue to evolve in order to develop compounds that adhere to the ideal characteristics for novel antimalarial therapeutics and to avoid high attrition rates pre- and post-clinic. In the present review, we aim to examine the contribution that SBDD has made to current antimalarial drug development efforts, covering hit discovery to lead optimization and prevention of parasite resistance. Finally, the potential for structural biology, particularly high-throughput structural genomics programmes, to identify future targets for drug discovery are discussed.<\/jats:p>","DOI":"10.1042\/bj20140240","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T08:00:46Z","timestamp":1404979246000},"page":"349-369","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["From crystal to compound: structure-based antimalarial drug discovery"],"prefix":"10.1042","volume":"461","author":[{"given":"Nyssa","family":"Drinkwater","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Monash University, Clayton Campus, Melbourne, VIC 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"McGowan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Monash University, Clayton Campus, Melbourne, VIC 3800, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2014,7,10]]},"reference":[{"key":"2021112216002488500_B1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1128\/CMR.15.4.595-612.2002","article-title":"History of human parasitology","volume":"15","author":"Cox","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"2021112216002488500_B2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11230-004-6354-6","article-title":"Plasmodium dominicana n. sp. (Plasmodiidae: Haemospororida) from Tertiary Dominican amber","volume":"61","author":"Poinar","year":"2005","journal-title":"Syst. Parasitol."},{"key":"2021112216002488500_B3","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/bmj.329.7475.1156","article-title":"Traditional herbal medicines for malaria","volume":"329","author":"Willcox","year":"2004","journal-title":"BMJ"},{"key":"2021112216002488500_B4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1365-2125.2006.02673.x","article-title":"Reflections on the \u2018discovery\u2019 of the antimalarial qinghao","volume":"61","author":"Hsu","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2021112216002488500_B5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/molecules15020804","article-title":"Ancient Chinese methods are remarkably effective for the preparation of artemisinin-rich extracts of qing hao with potent antimalarial activity","volume":"15","author":"Wright","year":"2010","journal-title":"Molecules"},{"key":"2021112216002488500_B6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/MAJ.0b013e3181e7fe6c","article-title":"Malaria, a journey in time: in search of the lost myths and forgotten stories","volume":"340","author":"Neghina","year":"2010","journal-title":"Am. J. Med. Sci."},{"key":"2021112216002488500_B7","volume-title":"The Miraculous Fever-Tree: Malaria, Medicine and the Cure That Changed the World","author":"Rocco","year":"2003"},{"key":"2021112216002488500_B8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2021112216002488500_B9","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2021112216002488500_B10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1056\/NEJMc0900231","article-title":"Artemisinin-resistant malaria in Asia","volume":"361","author":"Noedl","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2021112216002488500_B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1126\/science.1215966","article-title":"A major genome region underlying artemisinin resistance in malaria","volume":"336","author":"Cheeseman","year":"2012","journal-title":"Science"},{"key":"2021112216002488500_B12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1517\/17460441.2013.843522","article-title":"Novel approaches in antimalarial drug discovery","volume":"8","author":"Held","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"2021112216002488500_B13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery: approaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"2021112216002488500_B14","first-page":"1333","article-title":"Combating susceptibility to drug resistance: lessons from HIV-1 protease","volume":"11","author":"King","year":"2004","journal-title":"Chem. Biol."},{"key":"2021112216002488500_B15","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3390\/v2112509","article-title":"Molecular basis for drug resistance in HIV-1 protease","volume":"2","author":"Ali","year":"2010","journal-title":"Viruses"},{"key":"2021112216002488500_B16","doi-asserted-by":"publisher","first-page":"20986","DOI":"10.1073\/pnas.1006370107","article-title":"Drug resistance against HCV NS3\/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding","volume":"107","author":"Romano","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B17","doi-asserted-by":"publisher","first-page":"16823","DOI":"10.1073\/pnas.1204556109","article-title":"Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target","volume":"109","author":"Yuthavong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/1389557511209030210","article-title":"New targets, new hope: novel drug targets for curbing malaria","volume":"2012","author":"Arora","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"2021112216002488500_B19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1126\/science.1205216","article-title":"Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets","volume":"333","author":"Yuan","year":"2011","journal-title":"Science"},{"key":"2021112216002488500_B20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.2174\/156802611795429194","article-title":"The state of the art in anti-malaria drug discovery and development","volume":"11","author":"Burrows","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"2021112216002488500_B21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"2021112216002488500_B22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical genetics of Plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"2021112216002488500_B23","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"2021112216002488500_B24","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"Baird","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"2021112216002488500_B25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd2960","article-title":"A pre-emptive strike against malaria's stealthy hepatic forms","volume":"8","author":"Mazier","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021112216002488500_B26","doi-asserted-by":"publisher","first-page":"e1002178","DOI":"10.1371\/journal.ppat.1002178","article-title":"The next opportunity in anti-malaria drug discovery: the liver stage","volume":"7","author":"Derbyshire","year":"2011","journal-title":"PLoS Pathog."},{"key":"2021112216002488500_B27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.pt.2009.09.002","article-title":"Redefining the role of de novo fatty acid synthesis in Plasmodium parasites","volume":"25","author":"Tarun","year":"2009","journal-title":"Trends Parasitol."},{"key":"2021112216002488500_B28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1462-5822.2008.01270.x","article-title":"Type II fatty acid synthesis is essential only for malaria parasite late liver stage development","volume":"11","author":"Vaughan","year":"2009","journal-title":"Cell. Microbiol."},{"key":"2021112216002488500_B29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.chom.2008.08.007","article-title":"The caspase-1 inflammasome: a pilot of innate immune responses","volume":"4","author":"Yu","year":"2008","journal-title":"Cell Host Microbe"},{"key":"2021112216002488500_B30","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1021\/ci800297v","article-title":"Mechanical features of Plasmodium falciparum acyl carrier protein in the delivery of substrates","volume":"48","author":"Colizzi","year":"2008","journal-title":"J. Chem. Inf. Model."},{"key":"2021112216002488500_B31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.sbi.2008.09.008","article-title":"The multienzyme architecture of eukaryotic fatty acid synthases","volume":"18","author":"Leibundgut","year":"2008","journal-title":"Curr. Opin. Struct. Biol."},{"key":"2021112216002488500_B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0005-2760(96)00056-2","article-title":"Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis","volume":"1302","author":"Rock","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"2021112216002488500_B33","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1042\/BJ20041051","article-title":"FAS't inhibition of malaria","volume":"383","author":"Surolia","year":"2004","journal-title":"Biochem. J."},{"key":"2021112216002488500_B34","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1074\/jbc.M705566200","article-title":"Structural basis for catalytic and inhibitory mechanisms of \u03b2-hydroxyacyl-acyl carrier protein dehydratase (FabZ)","volume":"283","author":"Zhang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B35","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1110\/ps.051373005","article-title":"The crystal structure of PfFabZ, the unique \u03b2-hydroxyacyl-ACP dehydratase involved in fatty acid biosynthesis of Plasmodium falciparum","volume":"14","author":"Kostrewa","year":"2005","journal-title":"Protein Sci."},{"key":"2021112216002488500_B36","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.febslet.2006.04.014","article-title":"Crystal structure of dimeric FabZ of Plasmodium falciparum reveals conformational switching to active hexamers by peptide flips","volume":"580","author":"Swarnamukhi","year":"2006","journal-title":"FEBS Lett."},{"key":"2021112216002488500_B37","doi-asserted-by":"publisher","first-page":"45661","DOI":"10.1074\/jbc.M304283200","article-title":"Identification, characterization, and inhibition of Plasmodium falciparum \u03b2-hydroxyacyl-acyl carrier protein dehydratase (FabZ)","volume":"278","author":"Sharma","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B38","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1099\/mic.0.2008\/017434-0","article-title":"Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636","volume":"154","author":"Bhowruth","year":"2008","journal-title":"Microbiology"},{"key":"2021112216002488500_B39","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/AAC.00968-07","article-title":"Antimycobacterial activity and mechanism of action of NAS-91","volume":"52","author":"Gratraud","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021112216002488500_B40","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jsb.2011.07.018","article-title":"Structural basis for the functional and inhibitory mechanisms of \u03b2-hydroxyacyl-acyl carrier protein dehydratase (FabZ) of Plasmodium falciparum","volume":"176","author":"Maity","year":"2011","journal-title":"J. Struct. Biol."},{"key":"2021112216002488500_B41","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1021\/jm0600545","article-title":"Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids","volume":"49","author":"Tasdemir","year":"2006","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/84612","article-title":"Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum","volume":"7","author":"Surolia","year":"2001","journal-title":"Nat. Med."},{"key":"2021112216002488500_B43","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1074\/jbc.M112000200","article-title":"Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase","volume":"277","author":"Perozzo","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B44","doi-asserted-by":"publisher","first-page":"8086","DOI":"10.1016\/j.bmc.2006.07.034","article-title":"Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli","volume":"14","author":"Chhibber","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"2021112216002488500_B45","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1016\/j.bmcl.2005.08.044","article-title":"Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4\u2032-substituted triclosan derivatives","volume":"15","author":"Freundlich","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021112216002488500_B46","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.bmcl.2006.01.051","article-title":"Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2\u2032-substituted triclosan derivatives","volume":"16","author":"Freundlich","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021112216002488500_B47","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/iub.327","article-title":"X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition","volume":"62","author":"Maity","year":"2010","journal-title":"IUBMB Life"},{"key":"2021112216002488500_B48","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1021\/jm400637m","article-title":"Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabl)","volume":"56","author":"Belluti","year":"2013","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B49","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2174\/1386207043328544","article-title":"Privileged structures: applications in drug discovery","volume":"7","author":"DeSimone","year":"2004","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"2021112216002488500_B50","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1073\/pnas.102679799","article-title":"Structure of 2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase: an essential enzyme for isoprenoid biosynthesis and target for antimicrobial drug development","volume":"99","author":"Kemp","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B51","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/0039-128X(92)90081-J","article-title":"Sterol molecule: structure, biosynthesis, and function","volume":"57","author":"Bloch","year":"1992","journal-title":"Steroids"},{"key":"2021112216002488500_B52","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1042\/bj2950517","article-title":"Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate","volume":"295","author":"Rohmer","year":"1993","journal-title":"Biochem. J."},{"key":"2021112216002488500_B53","doi-asserted-by":"publisher","first-page":"R221","DOI":"10.1016\/S1074-5521(98)90002-3","article-title":"The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms","volume":"5","author":"Eisenreich","year":"1998","journal-title":"Chem. Biol."},{"key":"2021112216002488500_B54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molbiopara.2009.12.001","article-title":"Functional genetic analysis of the Plasmodium falciparum deoxyxylulose 5-phosphate reductoisomerase gene","volume":"170","author":"Odom","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112216002488500_B55","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","article-title":"Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs","volume":"285","author":"Jomaa","year":"1999","journal-title":"Science"},{"key":"2021112216002488500_B56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1042\/0264-6021:3410629","article-title":"Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units","volume":"341","author":"Couto","year":"1999","journal-title":"Biochem. J."},{"key":"2021112216002488500_B57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.7164\/antibiotics.33.18","article-title":"Studies on new phosphonic acid antibiotics. 2. Taxonomic studies on producing organisms of the phosphonic acid and related-compounds","volume":"33","author":"Iguchi","year":"1980","journal-title":"J. Antibiot."},{"key":"2021112216002488500_B58","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(02)11860-5","article-title":"Fosmidomycin for malaria","volume":"360","author":"Missinou","year":"2002","journal-title":"Lancet"},{"key":"2021112216002488500_B59","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1128\/AAC.47.2.735-738.2003","article-title":"Fosmidomycin, a novel chemotherapeutic agent for malaria","volume":"47","author":"Lell","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021112216002488500_B60","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1086\/424603","article-title":"Fosmidomycin\u2013clindamycin for the treatment of Plasmodium falciparum malaria","volume":"190","author":"Borrmann","year":"2004","journal-title":"J. Infect. Dis."},{"key":"2021112216002488500_B61","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1016\/j.bmc.2007.12.001","article-title":"Synthesis of \u03b2- and \u03b3-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates","volume":"16","author":"Haemers","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"2021112216002488500_B62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/ml300419r","article-title":"Antimalarial and structural studies of pyridine-containing inhibitors of 1-deoxyxylulose-5-phosphate reductoisomerase","volume":"4","author":"Xue","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"2021112216002488500_B63","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/srep00009","article-title":"Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum","volume":"1","author":"Umeda","year":"2011","journal-title":"Sci. Rep."},{"key":"2021112216002488500_B64","doi-asserted-by":"publisher","first-page":"6796","DOI":"10.1021\/jm200694q","article-title":"Reverse fosmidomycin derivatives against the antimalarial drug target IspC (Dxr)","volume":"54","author":"Behrendt","year":"2011","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B65","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1021\/ml100243r","article-title":"Structures of 1-deoxy-D-xylulose-5-phosphate reductoisomerase\/lipophilic phosphonate complexes","volume":"2","author":"Deng","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"2021112216002488500_B66","doi-asserted-by":"publisher","first-page":"8151","DOI":"10.1021\/jm4012559","article-title":"IspC as target for antiinfective drug discovery: synthesis, enantiomeric separation, and structural biology of fosmidomycin thia isosters","volume":"56","author":"Kunfermann","year":"2013","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B67","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/jm9911027","article-title":"Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts","volume":"43","author":"Calas","year":"2000","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B68","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1126\/science.1067236","article-title":"A class of potent antimalarials and their specific accumulation in infected erythrocytes","volume":"295","author":"Wengelnik","year":"2002","journal-title":"Science"},{"key":"2021112216002488500_B69","doi-asserted-by":"publisher","first-page":"27636","DOI":"10.1074\/jbc.M804360200","article-title":"Disruption of the Plasmodium falciparum PfPMT gene results in a complete loss of phosphatidylcholine biosynthesis via the serine-decarboxylase\u2013phosphoethanolamine-methyltransferase pathway and severe growth and survival defects","volume":"283","author":"Witola","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B70","doi-asserted-by":"publisher","first-page":"12461","DOI":"10.1074\/jbc.M414626200","article-title":"In\u00a0vivo evidence for the specificity of Plasmodium falciparum phosphoethanolamine methyltransferase and its coupling to the Kennedy pathway","volume":"280","author":"Pessi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B71","doi-asserted-by":"publisher","first-page":"7894","DOI":"10.1074\/jbc.M709869200","article-title":"Biochemical and genetic analysis of the phosphoethanolamine methyltransferase of the human malaria parasite Plasmodium falciparum","volume":"283","author":"Reynolds","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B72","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1073\/pnas.0307742101","article-title":"A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation","volume":"101","author":"Pessi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B73","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1574-6976.2011.00267.x","article-title":"Phosphoethanolamine methyltransferases in phosphocholine biosynthesis: functions and potential for antiparasite therapy","volume":"35","author":"Bobenchik","year":"2011","journal-title":"FEMS Microbiol. Immunol."},{"key":"2021112216002488500_B74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2091-11-4","article-title":"Identification of inhibitors of Plasmodium falciparum phosphoethanolamine methyltransferase using an enzyme-coupled transmethylation assay","volume":"11","author":"Bobenchik","year":"2010","journal-title":"BMC Biochem."},{"key":"2021112216002488500_B75","doi-asserted-by":"publisher","first-page":"38060","DOI":"10.1074\/jbc.M111.290619","article-title":"Thermodynamic evaluation of ligand binding in the plant-like phosphoethanolamine methyltransferases of the parasitic nematode Haemonchus contortus","volume":"286","author":"Lee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0014-4894(80)90010-7","article-title":"Plasmodium falciparum: antimalarial activity in culture of sinefungin and other methylation inhibitors","volume":"50","author":"Trager","year":"1980","journal-title":"Exp. Parasitol."},{"key":"2021112216002488500_B77","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1074\/jbc.M111.315267","article-title":"Structure and reaction mechanism of phosphoethanolamine methyltransferase from the malaria parasite Plasmodium falciparum: an antiparasitic drug target","volume":"287","author":"Lee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B78","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1016\/j.bmcl.2012.06.032","article-title":"Crystal structure of phosphoethanolamine methyltransferase from Plasmodium falciparum in complex with amodiaquine","volume":"22","author":"Lee","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021112216002488500_B79","doi-asserted-by":"publisher","first-page":"18262","DOI":"10.1073\/pnas.1313965110","article-title":"Plasmodium falciparum phosphoethanolamine methyltransferase is essential for malaria transmission","volume":"110","author":"Bobenchik","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B80","doi-asserted-by":"publisher","first-page":"9547","DOI":"10.1074\/jbc.M412693200","article-title":"Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins","volume":"280","author":"Ting","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B81","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.2174\/092986710791556023","article-title":"Inhibitors of the purine salvage pathway: a valuable approach for antiprotozoal chemotherapy?","volume":"17","author":"Berg","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"2021112216002488500_B82","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/9367","article-title":"Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases","volume":"6","author":"Li","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"2021112216002488500_B83","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.chembiol.2012.04.012","article-title":"Acyclic immucillin phosphonates: second-generation inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase","volume":"19","author":"Hazleton","year":"2012","journal-title":"Chem. Biol."},{"key":"2021112216002488500_B84","doi-asserted-by":"publisher","first-page":"9872","DOI":"10.1021\/bi990664p","article-title":"The 2.0 \u00c5 structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor","volume":"38","author":"Shi","year":"1999","journal-title":"Biochemistry"},{"key":"2021112216002488500_B85","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/9376","article-title":"The 2.0 \u00c5 structure of human hypoxanthine-guanine phosphoribosyltransferase in complex with a transition-state analog inhibitor","volume":"6","author":"Shi","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"2021112216002488500_B86","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1021\/jm900267n","article-title":"Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics","volume":"52","author":"Keough","year":"2009","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B87","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.molbiopara.2010.05.018","article-title":"Plasmodium vivax hypoxanthine-guanine phosphoribosyltransferase: a target for anti-malarial chemotherapy","volume":"173","author":"Keough","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112216002488500_B88","doi-asserted-by":"publisher","first-page":"6209","DOI":"10.1021\/jm300662d","article-title":"Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases","volume":"55","author":"Hockova","year":"2012","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B89","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1021\/jm301893b","article-title":"Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of 6-oxopurine phosphoribosyltransferases and have antimalarial activity","volume":"56","author":"Keough","year":"2013","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B90","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1021\/jm701260b","article-title":"Prodrugs of phosphates and phosphonates","volume":"51","author":"Hecker","year":"2008","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B91","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2174\/156802611796575948","article-title":"Purine and pyrimidine pathways as targets in Plasmodium falciparum","volume":"11","author":"Cassera","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"2021112216002488500_B92","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1074\/jbc.M105906200","article-title":"Purine-less death in Plasmodium falciparum induced by immucillin-H, a transition state analogue of purine nucleoside phosphorylase","volume":"277","author":"Kicska","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B93","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.femsre.2005.03.004","article-title":"Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy","volume":"29","author":"de Koning","year":"2005","journal-title":"FEMS Microbiol. Immunol."},{"key":"2021112216002488500_B94","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0166-6851(82)90035-4","article-title":"Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum","volume":"5","author":"Reyes","year":"1982","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112216002488500_B95","doi-asserted-by":"publisher","first-page":"14489","DOI":"10.1021\/bi026636f","article-title":"Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase","volume":"41","author":"Kicska","year":"2002","journal-title":"Biochemistry"},{"key":"2021112216002488500_B96","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1021\/bi700147b","article-title":"Neighboring group participation in the transition state of purine nucleoside phosphorylase","volume":"46","author":"Murkin","year":"2007","journal-title":"Biochemistry"},{"key":"2021112216002488500_B97","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1021\/bi700147b","article-title":"Neighboring group participation in the transition state of human purine nucleoside phosphorylase","volume":"46","author":"Murkin","year":"2007","journal-title":"Biochemistry"},{"key":"2021112216002488500_B98","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1021\/ja7104398","article-title":"Transition-state interactions revealed in purine nucleoside phosphorylase by binding isotope effects","volume":"130","author":"Murkin","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"2021112216002488500_B99","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1021\/ja710733g","article-title":"L-Enantiomers of transition state analogue inhibitors bound to human purine nucleoside phosphorylase","volume":"130","author":"Rinaldo-Matthis","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"2021112216002488500_B100","doi-asserted-by":"publisher","first-page":"18103","DOI":"10.1074\/jbc.C400068200","article-title":"Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function","volume":"279","author":"Shi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B101","doi-asserted-by":"publisher","first-page":"e26916","DOI":"10.1371\/journal.pone.0026916","article-title":"Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal model","volume":"6","author":"Cassera","year":"2011","journal-title":"PLoS ONE"},{"key":"2021112216002488500_B102","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/jb\/mvm193","article-title":"Structural basis for the decarboxylation of orotidine 5\u2032-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase","volume":"143","author":"Tokuoka","year":"2008","journal-title":"J. Biochem. (Tokyo)"},{"key":"2021112216002488500_B103","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/jb\/mvs070","article-title":"The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5\u2032-monophosphate decarboxylase","volume":"152","author":"Takashima","year":"2012","journal-title":"J. Biochem. (Tokyo)"},{"key":"2021112216002488500_B104","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jmgm.2005.11.006","article-title":"Multiple target screening method for robust and accurate in silico ligand screening","volume":"25","author":"Fukunishi","year":"2006","journal-title":"J. Mol. Graph. Model."},{"key":"2021112216002488500_B105","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1021\/jm050480a","article-title":"Classification of chemical compounds by protein-compound docking for use in designing a focused library","volume":"49","author":"Fukunishi","year":"2006","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B106","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1073\/pnas.83.8.2584","article-title":"Primary structure of the gene encoding the bifunctional dihydrofolate reductase\u2013thymidylate synthase of Leishmania major","volume":"83","author":"Beverley","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B107","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1021\/jm00381a008","article-title":"Receptor-based design of dihydrofolate-reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprime analogs","volume":"28","author":"Kuyper","year":"1985","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B108","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1128\/AAC.01526-09","article-title":"Preclinical evaluation of the antifolate QN254, 5-chloro-N'6\u2032-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate","volume":"54","author":"Nzila","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021112216002488500_B109","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrd1129","article-title":"Implications of protein flexibility for drug discovery","volume":"2","author":"Teague","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021112216002488500_B110","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/COH.0b013e3283136cee","article-title":"New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors","volume":"3","author":"Nalam","year":"2008","journal-title":"Curr. Opin. HIV AIDS."},{"key":"2021112216002488500_B111","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S0031182008005301","article-title":"Mutational, inhibitory and microcalorimetric analyses of Plasmodium falciparum TMP kinase: implications for drug discovery","volume":"136","author":"Kandeel","year":"2009","journal-title":"Parasitology"},{"key":"2021112216002488500_B112","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1042\/BJ20091880","article-title":"Structural basis for the efficient phosphorylation of AZT-MP (3\u2032-azido-3\u2032-deoxythymidine monophosphate) and dGMP by Plasmodium falciparum type\u00a0I thymidylate kinase","volume":"428","author":"Whittingham","year":"2010","journal-title":"Biochem. J."},{"key":"2021112216002488500_B113","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1016\/j.bmc.2010.07.006","article-title":"Potential application of thymidylate kinase in nucleoside analogue activation in Plasmodium falciparum","volume":"18","author":"Cui","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"2021112216002488500_B114","doi-asserted-by":"publisher","first-page":"10948","DOI":"10.1021\/jm301328h","article-title":"Synthesis and evaluation of \u03b1-thymidine analogues as novel antimalarials","volume":"55","author":"Cui","year":"2012","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B115","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1021\/jm0706158","article-title":"Rational design of 5\u2032-thiourea-substituted \u03b1-thymidine analogues as thymidine monophosphate kinase inhibitors capable of inhibiting mycobacterial growth","volume":"50","author":"Van Daele","year":"2007","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B116","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1021\/ar800114w","article-title":"Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases","volume":"42","author":"Vertessy","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"2021112216002488500_B117","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1110\/ps.48801","article-title":"Kinetic properties and inhibition of the dimeric dUTPase\u2013dUDPase from Leishmania major","volume":"10","author":"Hidalgo-Zarco","year":"2001","journal-title":"Protein Sci."},{"key":"2021112216002488500_B118","doi-asserted-by":"crossref","first-page":"159","DOI":"10.18388\/abp.1997_4410","article-title":"dUTP pyrophosphatase as a potential target for chemotherapeutic drug development","volume":"44","author":"McIntosh","year":"1997","journal-title":"Acta Biochim. Polon."},{"key":"2021112216002488500_B119","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/jb.170.3.1069-1075.1988","article-title":"Lethality of a dUT (deoxyuridine triphosphatase) mutation in Escherichia coli","volume":"170","author":"Elhajj","year":"1988","journal-title":"J. Bacteriol."},{"key":"2021112216002488500_B120","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1002\/j.1460-2075.1993.tb06127.x","article-title":"dUTP pyrophosphatase is an essential enzyme in Saccharomyces cerevisiae","volume":"12","author":"Gadsden","year":"1993","journal-title":"EMBO J."},{"key":"2021112216002488500_B121","doi-asserted-by":"publisher","first-page":"5942","DOI":"10.1021\/jm050111e","article-title":"Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target","volume":"48","author":"Nguyen","year":"2005","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B122","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1021\/jm060126s","article-title":"Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase","volume":"49","author":"Nguyen","year":"2006","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B123","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.str.2004.11.015","article-title":"dUTPase as a platform for antimalarial drug design: structural basis for the selectivity of a class of nucleoside inhibitors","volume":"13","author":"Whittingham","year":"2005","journal-title":"Structure"},{"key":"2021112216002488500_B124","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.ejmech.2008.05.018","article-title":"Design, synthesis and evaluation of novel uracil acetamide derivatives as potential inhibitors of Plasmodium falciparum dUTP nucleotidohydrolase","volume":"44","author":"McCarthy","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"2021112216002488500_B125","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.bmc.2011.02.012","article-title":"\u03b2-Branched acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase","volume":"19","author":"Baragana","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"2021112216002488500_B126","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1002\/cmdc.201100255","article-title":"Design, synthesis, and evaluation of 5\u2032-diphenyl nucleoside analogues as inhibitors of the Plasmodium falciparum dUTPase","volume":"6","author":"Hampton","year":"2011","journal-title":"ChemMedChem"},{"key":"2021112216002488500_B127","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential","volume":"54","author":"Coteron","year":"2011","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B128","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1021\/jm801343r","article-title":"Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice","volume":"52","author":"Gujjar","year":"2009","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B129","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1021\/jm8001026","article-title":"Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum","volume":"51","author":"Phillips","year":"2008","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B130","doi-asserted-by":"publisher","first-page":"21847","DOI":"10.1074\/jbc.M501100200","article-title":"High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase","volume":"280","author":"Baldwin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B131","doi-asserted-by":"publisher","first-page":"26999","DOI":"10.1074\/jbc.M109.028589","article-title":"Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds","volume":"284","author":"Deng","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B132","doi-asserted-by":"publisher","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model","volume":"285","author":"Booker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B133","doi-asserted-by":"publisher","first-page":"35078","DOI":"10.1074\/jbc.M804990200","article-title":"Identification and characterization of small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase","volume":"283","author":"Patel","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B134","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1021\/jm300157n","article-title":"Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases","volume":"55","author":"Bedingfield","year":"2012","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B135","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1107\/S0907444905042642","article-title":"Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor","volume":"62","author":"Hurt","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2021112216002488500_B136","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1021\/jm200265b","article-title":"Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice","volume":"54","author":"Gujjar","year":"2011","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B137","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/cmdc.200700301","article-title":"N-myristoyltransferase: a prospective drug target for protozoan parasites","volume":"3","author":"Bowyer","year":"2008","journal-title":"ChemMedChem"},{"key":"2021112216002488500_B138","doi-asserted-by":"publisher","first-page":"e1625","DOI":"10.1371\/journal.pntd.0001625","article-title":"Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs","volume":"6","author":"Bell","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2021112216002488500_B139","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1021\/jm300040p","article-title":"Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode","volume":"55","author":"Goncalves","year":"2012","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B140","doi-asserted-by":"publisher","first-page":"8879","DOI":"10.1021\/jm301160h","article-title":"Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery","volume":"55","author":"Yu","year":"2012","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B141","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1021\/jm301474t","article-title":"Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase","volume":"56","author":"Rackham","year":"2013","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B142","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1021\/jm500066b","article-title":"Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP)","volume":"57","author":"Rackham","year":"2014","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B143","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchem.1830","article-title":"Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach","volume":"6","author":"Wright","year":"2014","journal-title":"Nat. Chem."},{"key":"2021112216002488500_B144","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1073\/pnas.0510907103","article-title":"Structure of the MTIP\u2013MyoA complex, a key component of the malaria parasite invasion motor","volume":"103","author":"Bosch","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B145","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jmb.2007.06.016","article-title":"The closed MTIP\u2013myosin A\u2013tail complex from the malaria parasite invasion machinery","volume":"372","author":"Bosch","year":"2007","journal-title":"J. Mol. Biol."},{"key":"2021112216002488500_B146","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/ci100039k","article-title":"Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum","volume":"50","author":"Kortagere","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"2021112216002488500_B147","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC: a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"2021112216002488500_B148","doi-asserted-by":"publisher","first-page":"14815","DOI":"10.1074\/jbc.M109.080770","article-title":"Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites","volume":"285","author":"Richard","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B149","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2174\/156802611796575885","article-title":"Apical membrane antigen 1 as an anti-malarial drug target","volume":"11","author":"Macraild","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"2021112216002488500_B150","doi-asserted-by":"publisher","first-page":"12736","DOI":"10.1073\/pnas.0501808102","article-title":"Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket","volume":"102","author":"Bai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B151","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/bip.21582","article-title":"Peptide inhibitors of the malaria surface protein, apical membrane antigen 1: identification of key binding residues","volume":"95","author":"Lee","year":"2011","journal-title":"Biopolymers"},{"key":"2021112216002488500_B152","doi-asserted-by":"publisher","first-page":"e1002755","DOI":"10.1371\/journal.ppat.1002755","article-title":"Structural and functional insights into the malaria parasite moving junction complex","volume":"8","author":"Vulliez-Le Normand","year":"2012","journal-title":"PLoS Pathog."},{"key":"2021112216002488500_B153","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/ncomms3261","article-title":"Disrupting malaria parasite AMA1\u2013RON2 interaction with a small molecule prevents erythrocyte invasion","volume":"4","author":"Srinivasan","year":"2013","journal-title":"Nat. Commun."},{"key":"2021112216002488500_B154","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1111\/j.1462-5822.2008.01176.x","article-title":"Malarial proteases and host cell egress: an \u2018emerging\u2019 cascade","volume":"10","author":"Blackman","year":"2008","journal-title":"Cell. Microbiol."},{"key":"2021112216002488500_B155","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-0-387-78267-6","article-title":"Roles of proteases during invasion and egress by Plasmodium and Toxoplasma","volume":"47","author":"Dowse","year":"2008","journal-title":"Subcell. Biochem."},{"key":"2021112216002488500_B156","doi-asserted-by":"publisher","first-page":"18561","DOI":"10.1074\/jbc.M113.456764","article-title":"In silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound","volume":"288","author":"Bouillon","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B157","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ijpara.2012.04.005","article-title":"Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target","volume":"42","author":"Withers-Martinez","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"2021112216002488500_B158","doi-asserted-by":"publisher","first-page":"21793","DOI":"10.1074\/jbc.270.37.21793","article-title":"BTS1 encodes a geranylgeranyl diphosphate synthase in Saccharomyces cerevisiae","volume":"270","author":"Jiang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B159","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0166-6851(98)00065-6","article-title":"Protein prenyl transferase activities of Plasmodium falciparum","volume":"94","author":"Chakrabarti","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112216002488500_B160","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1073\/pnas.1118215109","article-title":"Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity","volume":"109","author":"No","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B161","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1074\/jbc.M109.027235","article-title":"Molecular characterization of a novel geranylgeranyl pyrophosphate synthase from Plasmodium parasites","volume":"286","author":"Artz","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B162","doi-asserted-by":"publisher","first-page":"7827","DOI":"10.1021\/jm8009074","article-title":"Bisphosphonate inhibition of a Plasmodium farnesyl diphosphate synthase and a general method for predicting cell-based activity from enzyme data","volume":"51","author":"Mukkamala","year":"2008","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B163","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1021\/jm0002578","article-title":"Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy","volume":"44","author":"Martin","year":"2001","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B164","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nrd3053","article-title":"Emerging principles in protease-based drug discovery","volume":"9","author":"Drag","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"2021112216002488500_B165","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1073\/pnas.022630099","article-title":"Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine","volume":"99","author":"Banerjee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B166","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.biochem.71.090501.145453","article-title":"Biological roles of proteases in parasitic protozoa","volume":"71","author":"Klemba","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"2021112216002488500_B167","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0014-5793(99)00276-8","article-title":"A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum","volume":"447","author":"Berry","year":"1999","journal-title":"FEBS Lett."},{"key":"2021112216002488500_B168","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1172\/JCI117140","article-title":"Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway","volume":"93","author":"Gluzman","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2021112216002488500_B169","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/QCO.0b013e328315cca9","article-title":"Development of protease inhibitors for protozoan infections","volume":"21","author":"McKerrow","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"2021112216002488500_B170","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2958.2007.05768.x","article-title":"Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function","volume":"65","author":"Bonilla","year":"2007","journal-title":"Mol. Microbiol."},{"key":"2021112216002488500_B171","doi-asserted-by":"publisher","first-page":"8293","DOI":"10.1002\/anie.200903747","article-title":"Functional profiling, identification, and inhibition of plasmepsins in intraerythrocytic malaria parasites","volume":"48","author":"Liu","year":"2009","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2021112216002488500_B172","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1021\/bi802059r","article-title":"Recombinant plasmepsin 1 from the human malaria parasite Plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis","volume":"48","author":"Liu","year":"2009","journal-title":"Biochemistry"},{"key":"2021112216002488500_B173","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/978-1-4615-1871-6","article-title":"Design and synthesis of HIV protease inhibitors containing allophenylnorstatine as a transition-state mimic","volume":"362","author":"Kiso","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021112216002488500_B174","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/(SICI)1099-081X(199603)17:2&lt;125::AID-BDD940&gt;3.0.CO;2-5","article-title":"The bioavailability of oral dosage forms of a new HIV-1 protease inhibitor, KNI-272, in beagle dogs","volume":"17","author":"Kiriyama","year":"1996","journal-title":"Biopharm. Drug Dispos."},{"key":"2021112216002488500_B175","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbapap.2011.04.008","article-title":"Structural studies of vacuolar plasmepsins","volume":"1824","author":"Bhaumik","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"2021112216002488500_B176","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1107\/S0907444905041260","article-title":"Structure of the aspartic protease plasmepsin 4 from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor","volume":"62","author":"Clemente","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2021112216002488500_B177","doi-asserted-by":"publisher","first-page":"8459","DOI":"10.1021\/bi034131z","article-title":"High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor","volume":"42","author":"Nezami","year":"2003","journal-title":"Biochemistry"},{"key":"2021112216002488500_B178","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jsb.2011.04.009","article-title":"Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum","volume":"175","author":"Bhaumik","year":"2011","journal-title":"J. Struct. Biol."},{"key":"2021112216002488500_B179","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jmb.2009.03.011","article-title":"Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum","volume":"388","author":"Bhaumik","year":"2009","journal-title":"J. Mol. Biol."},{"key":"2021112216002488500_B180","doi-asserted-by":"publisher","first-page":"8862","DOI":"10.1021\/bi201118z","article-title":"Structural insights into the activation and inhibition of histo-aspartic protease from Plasmodium falciparum","volume":"50","author":"Bhaumik","year":"2011","journal-title":"Biochemistry"},{"key":"2021112216002488500_B181","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/chem.201202941","article-title":"Potent inhibitors of malarial aspartic proteases, the plasmepsins, by hydroformylation of substituted 7-azanorbornenes","volume":"19","author":"Aureggi","year":"2013","journal-title":"Chemistry"},{"key":"2021112216002488500_B182","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1016\/j.bmcl.2011.04.015","article-title":"Identification of plasmepsin inhibitors as selective anti-malarial agents using ligand based drug design","volume":"21","author":"McKay","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021112216002488500_B183","doi-asserted-by":"publisher","first-page":"8721","DOI":"10.1073\/pnas.0402738101","article-title":"Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites","volume":"101","author":"Sijwali","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B184","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/AAC.47.1.154-160.2003","article-title":"Structure\u2013activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones","volume":"47","author":"Shenai","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021112216002488500_B185","doi-asserted-by":"publisher","first-page":"11503","DOI":"10.1073\/pnas.0600489103","article-title":"Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B186","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/jm8013663","article-title":"Structures of falcipain-2 and falcipain-3 bound to small molecule inhibitors: implications for substrate specificity","volume":"52","author":"Kerr","year":"2009","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B187","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2174\/156802612799362913","article-title":"Falcipain inhibition as a promising antimalarial target","volume":"12","author":"Marco","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"2021112216002488500_B188","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.2174\/0929867311320250003","article-title":"Development of Plasmodium falciparum protease inhibitors in the past decade (2002\u20132012)","volume":"20","author":"Perez","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"2021112216002488500_B189","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.bmcl.2014.01.062","article-title":"Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis of \u03b1-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum","volume":"24","author":"Weldon","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021112216002488500_B190","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1021\/ol1024663","article-title":"Total synthesis and antimalarial activity of symplostatin 4","volume":"12","author":"Conroy","year":"2010","journal-title":"Org. Lett."},{"key":"2021112216002488500_B191","doi-asserted-by":"publisher","first-page":"13544","DOI":"10.1002\/chem.201102538","article-title":"Total synthesis, stereochemical assignment, and antimalarial activity of gallinamide A","volume":"17","author":"Conroy","year":"2011","journal-title":"Chemistry"},{"key":"2021112216002488500_B192","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1021\/np070280x","article-title":"Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine cyanobacterium Symploca sp","volume":"71","author":"Linington","year":"2008","journal-title":"J. Nat. Prod."},{"key":"2021112216002488500_B193","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.chembiol.2012.09.020","article-title":"The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains","volume":"19","author":"Stolze","year":"2012","journal-title":"Chem. Biol."},{"key":"2021112216002488500_B194","doi-asserted-by":"publisher","first-page":"43000","DOI":"10.1074\/jbc.M408123200","article-title":"A Plasmodium falciparum dipeptidyl aminopeptidase I participates in vacuolar hemoglobin degradation","volume":"279","author":"Klemba","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B195","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.chembiol.2010.06.007","article-title":"Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes","volume":"17","author":"Deu","year":"2010","journal-title":"Chem. Biol."},{"key":"2021112216002488500_B196","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1128\/AAC.02495-12","article-title":"Plasmodium dipeptidyl aminopeptidases as malaria transmission-blocking drug targets","volume":"57","author":"Tanaka","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021112216002488500_B197","doi-asserted-by":"publisher","first-page":"35978","DOI":"10.1074\/jbc.M703643200","article-title":"Roles for two aminopeptidases in vacuolar hemoglobin catabolism in Plasmodium falciparum","volume":"282","author":"Dalal","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B198","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1073\/pnas.87.8.2931","article-title":"Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle","volume":"87","author":"Goldberg","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B199","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/00062752-200203000-00010","article-title":"Hydrolysis of erythrocyte proteins by proteases of malaria parasites","volume":"9","author":"Rosenthal","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"2021112216002488500_B200","doi-asserted-by":"publisher","first-page":"E526","DOI":"10.1073\/pnas.1105601108","article-title":"Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases","volume":"108","author":"Harbut","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B201","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.molbiopara.2010.05.007","article-title":"Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes","volume":"173","author":"Naughton","year":"2010","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112216002488500_B202","doi-asserted-by":"publisher","first-page":"30817","DOI":"10.1074\/jbc.M704938200","article-title":"The M18 aspartyl aminopeptidase of the human malaria parasite Plasmodium falciparum","volume":"282","author":"Teuscher","year":"2007","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B203","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1073\/pnas.0911813107","article-title":"Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases","volume":"107","author":"McGowan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B204","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1073\/pnas.0807398106","article-title":"Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase","volume":"106","author":"McGowan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B205","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1021\/jm070733v","article-title":"Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds","volume":"50","author":"Skinner-Adams","year":"2007","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B206","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1021\/jm4005972","article-title":"Synthesis and structure\u2013activity relationships of phosphonic arginine mimetics as inhibitors of the M1 and M17 aminopeptidases from Plasmodium falciparum","volume":"56","author":"Kannan Sivaraman","year":"2013","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B207","doi-asserted-by":"publisher","first-page":"e31938","DOI":"10.1371\/journal.pone.0031938","article-title":"Fingerprinting the substrate specificity of M1 and M17 neutral aminopeptidases of human malaria, Plasmodium falciparum","volume":"2","author":"Poreba","year":"2012","journal-title":"PLoS ONE"},{"key":"2021112216002488500_B208","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1016\/j.bmcl.2008.09.021","article-title":"Development of bestatin-based activity-based probes for metallo-aminopeptidases","volume":"18","author":"Harbut","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2021112216002488500_B209","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1021\/jm101227t","article-title":"Synthesis of new (\u2212)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase","volume":"54","author":"Velmourougane","year":"2011","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B210","doi-asserted-by":"publisher","first-page":"10909","DOI":"10.1021\/jm301506h","article-title":"Structure\u2013activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors","volume":"55","author":"Deprez-Poulain","year":"2012","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B211","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1021\/jm061169b","article-title":"Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents","volume":"50","author":"Flipo","year":"2007","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B212","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1128\/AAC.06245-11","article-title":"The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria","volume":"56","author":"Skinner-Adams","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"2021112216002488500_B213","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jmb.2012.06.006","article-title":"X-ray crystal structure and specificity of the Plasmodium falciparum malaria aminopeptidase PfM18AAP","volume":"422","author":"Sivaraman","year":"2012","journal-title":"J. Mol. Biol."},{"key":"2021112216002488500_B214","article-title":"Inhibitors of the Plasmodium falciparum M18 aspartyl aminopeptidase","volume-title":"Probe Reports from the NIH Molecular Libraries Program","author":"Schoenen","year":"2010"},{"key":"2021112216002488500_B215","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/465297a","article-title":"Drug discovery: priming the antimalarial pipeline","volume":"465","author":"Fidock","year":"2010","journal-title":"Nature"},{"key":"2021112216002488500_B216","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/cmdc.201000341","article-title":"Feeding the antimalarial pipeline","volume":"5","author":"Schlitzer","year":"2010","journal-title":"ChemMedChem"},{"key":"2021112216002488500_B217","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbapap.2003.11.023","article-title":"Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors","volume":"1697","author":"Droucheau","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"2021112216002488500_B218","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ncomms1558","article-title":"Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum","volume":"2","author":"Solyakov","year":"2011","journal-title":"Nat. Commun."},{"key":"2021112216002488500_B219","first-page":"624","article-title":"Suppression of Plasmodium berghei parasitemia by LiCl in an animal infection model","volume":"27","author":"Zakaria","year":"2010","journal-title":"Trop. Biomed."},{"key":"2021112216002488500_B220","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/qsar.200860193","article-title":"Comparative investigation of the ATP-binding site of human and plasmodial glycogen synthase kinase-3","volume":"28","author":"Kruggel","year":"2009","journal-title":"QSAR Comb. Sci."},{"key":"2021112216002488500_B221","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1017\/S0031182011000151","article-title":"Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases","volume":"138","author":"Osolodkin","year":"2011","journal-title":"Parasitology"},{"key":"2021112216002488500_B222","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1021\/jm301575n","article-title":"3,6-Diamino-4-(2-halophenyl)-2-benzoylthieno[2,3-b]pyridine-5-carbonitriles are selective inhibitors of Plasmodium falciparum glycogen synthase kinase-3","volume":"56","author":"Fugel","year":"2013","journal-title":"J. Med. Chem."},{"key":"2021112216002488500_B223","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0006-2952(94)90279-8","article-title":"Roles of peptidyl-prolyl cis\u2013trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporine-A, FK506, and rapamycin","volume":"48","author":"Bell","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"2021112216002488500_B224","doi-asserted-by":"publisher","first-page":"7575","DOI":"10.1021\/ja035176q","article-title":"A bifunctional molecule that displays context-dependent cellular activity","volume":"125","author":"Braun","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"2021112216002488500_B225","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-540-44834-1","article-title":"Regulation of peptide bond cis\/trans isomerization by enzyme catalysis and its implication in physiological processes","volume":"148","author":"Fischer","year":"2004","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"2021112216002488500_B226","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1128\/EC.00016-13","article-title":"Structural insights into substrate binding by PvFKBP35, a peptidylprolyl cis\u2013trans isomerase from the human malarial parasite Plasmodium vivax","volume":"12","author":"Alag","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"2021112216002488500_B227","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/pro.438","article-title":"NMR and crystallographic structures of the FK506 binding domain of human malarial parasite Plasmodium vivax FKBP35","volume":"19","author":"Alag","year":"2010","journal-title":"Protein Sci."},{"key":"2021112216002488500_B228","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1021\/bi800004u","article-title":"Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506","volume":"47","author":"Kotaka","year":"2008","journal-title":"Biochemistry"},{"key":"2021112216002488500_B229","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1038\/srep02501","article-title":"Small molecule Plasmodium FKBP35 inhibitor as a potential antimalaria agent","volume":"3","author":"Harikishore","year":"2013","journal-title":"Sci. Rep."},{"key":"2021112216002488500_B230","doi-asserted-by":"publisher","first-page":"177ra37","DOI":"10.1126\/scitranslmed.3005029","article-title":"Quinolone-3-diarylethers: a new class of antimalarial drug","volume":"5","author":"Nilsen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2021112216002488500_B231","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1179\/135100003225002853","article-title":"Thioredoxin reductase and glutathione synthesis in Plasmodium falciparum","volume":"8","author":"Muller","year":"2003","journal-title":"Redox Rep."},{"key":"2021112216002488500_B232","first-page":"499","article-title":"Oxidative stress and the redox status of malaria-infected erythrocytes","volume":"16","author":"Hunt","year":"1990","journal-title":"Blood Cells"},{"key":"2021112216002488500_B233","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1021\/bi3005076","article-title":"Discovery and biochemical characterization of Plasmodium thioredoxin reductase inhibitors from an antimalarial set","volume":"51","author":"Theobald","year":"2012","journal-title":"Biochemistry"},{"key":"2021112216002488500_B234","first-page":"171","article-title":"Structural model of the Plasmodium falciparum thioredoxin reductase: a novel target for antimalarial drugs","volume":"46","author":"Banerjee","year":"2009","journal-title":"J. Vector Borne Dis."},{"key":"2021112216002488500_B235","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.bbrc.2011.12.009","article-title":"Investigation of a potential mechanism for the inhibition of SmTGR by auranofin and its implications for Plasmodium falciparum inhibition","volume":"417","author":"Caroli","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112216002488500_B236","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.bbrc.2012.07.156","article-title":"Crystal structure of Plasmodium falciparum thioredoxin reductase, a validated drug target","volume":"425","author":"Boumis","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112216002488500_B237","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4161\/auto.7.2.13310","article-title":"Autophagy in protists","volume":"7","author":"Duszenko","year":"2011","journal-title":"Autophagy"},{"key":"2021112216002488500_B238","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1087025","article-title":"Discovery of gene function by expression profiling of the malaria parasite life cycle","volume":"301","author":"Le Roch","year":"2003","journal-title":"Science"},{"key":"2021112216002488500_B239","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jsb.2012.09.001","article-title":"Structural characterization and inhibition of the Plasmodium Atg8\u2013Atg3 interaction","volume":"180","author":"Hain","year":"2012","journal-title":"J. Struct. Biol."},{"key":"2021112216002488500_B240","doi-asserted-by":"publisher","first-page":"5600","DOI":"10.1021\/bi100390z","article-title":"Crystal structure of arginase from Plasmodium falciparum and implications for L-arginine depletion in malarial infection","volume":"49","author":"Dowling","year":"2010","journal-title":"Biochemistry"},{"key":"2021112216002488500_B241","doi-asserted-by":"publisher","first-page":"8107","DOI":"10.1021\/ja971312d","article-title":"Inhibition of Mn2+ 2-arginase by borate leads to the design of a transition state analogue inhibitor, 2(S)-amino-6-boronohexanoic acid","volume":"119","author":"Baggio","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"2021112216002488500_B242","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0167-4838(99)00271-X","article-title":"Structure and function of the methionine aminopeptidases","volume":"1477","author":"Lowther","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"2021112216002488500_B243","doi-asserted-by":"publisher","first-page":"14548","DOI":"10.1073\/pnas.0604101103","article-title":"Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216002488500_B244","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.chom.2012.04.015","article-title":"Selective and specific inhibition of the Plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin","volume":"11","author":"Hoepfner","year":"2012","journal-title":"Cell Host Microbe"},{"key":"2021112216002488500_B245","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1186\/gb-2009-10-2-r21","article-title":"Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum","volume":"10","author":"Dharia","year":"2009","journal-title":"Genome Biol."},{"key":"2021112216002488500_B246","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2217\/fmb.11.45","article-title":"Target identification and validation of novel antimalarials","volume":"6","author":"McNamara","year":"2011","journal-title":"Future Microbiol."},{"key":"2021112216002488500_B247","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"2021112216002488500_B248","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1021\/cb200105d","article-title":"A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor","volume":"6","author":"Nam","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"2021112216002488500_B249","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1146\/annurev.biochem.69.1.617","article-title":"Aminoacyl-tRNA synthesis","volume":"69","author":"Ibba","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"2021112216002488500_B250","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1146\/annurev.bi.62.070193.003435","article-title":"Cognition, mechanism, and evolutionary relationships in aminoacyl-transfer RNA-synthetases","volume":"62","author":"Carter","year":"1993","journal-title":"Annu. Rev. Biochem."},{"key":"2021112216002488500_B251","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1107\/S0907444913001923","article-title":"Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development","volume":"69","author":"Khan","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2021112216002488500_B252","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chembiol.2009.01.006","article-title":"Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in\u00a0vitro and in\u00a0vivo","volume":"16","author":"Chen","year":"2009","journal-title":"Chem. Biol."},{"key":"2021112216002488500_B253","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbrc.2011.07.045","article-title":"Crystal structure of Plasmodium falciparum phosphoglycerate kinase: evidence for anion binding in the basic patch","volume":"412","author":"Smith","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112216002488500_B254","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jmb.2010.11.018","article-title":"Specific inhibition of the aspartate aminotransferase of Plasmodium falciparum","volume":"405","author":"Wrenger","year":"2011","journal-title":"J. Mol. Biol."},{"key":"2021112216002488500_B255","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6807-14-1","article-title":"Crystal structures of IspF from Plasmodium falciparum and Burkholderia cenocepacia: comparisons inform antimicrobial drug target assessment","volume":"14","author":"O\u2019Rourke","year":"2014","journal-title":"BMC Struct. Biol."},{"key":"2021112216002488500_B256","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1016\/j.febslet.2013.10.029","article-title":"Structure of the (E)-4-hydroxy-3-methyl-but-2-enyl-diphosphate reductase from Plasmodium falciparum","volume":"587","author":"Rekittke","year":"2013","journal-title":"FEBS Lett."},{"key":"2021112216002488500_B257","doi-asserted-by":"publisher","first-page":"e66224","DOI":"10.1371\/journal.pone.0066224","article-title":"An appended domain results in an unusual architecture for malaria parasite tryptophanyl-tRNA synthetase","volume":"8","author":"Khan","year":"2013","journal-title":"PLoS ONE"},{"key":"2021112216002488500_B258","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molbiopara.2006.10.011","article-title":"Genome-scale protein expression and structural biology of Plasmodium falciparum and related apicomplexan organisms","volume":"151","author":"Vedadi","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112216002488500_B259","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/pro.226","article-title":"Crystallographic structure of the tetratricopeptide repeat domain of Plasmodium falciparum FKBP35 and its molecular interaction with Hsp90 C-terminal pentapeptide","volume":"18","author":"Alag","year":"2009","journal-title":"Protein Sci."},{"key":"2021112216002488500_B260","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.chembiol.2008.10.017","article-title":"Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis","volume":"15","author":"Artz","year":"2008","journal-title":"Chem. Biol."},{"key":"2021112216002488500_B261","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jmb.2007.07.053","article-title":"Crystal structure of Plasmodium falciparum spermidine synthase in complex with the substrate decarboxylated S-adenosylmethionine and the potent inhibitors 4MCHA and AdoDATO","volume":"373","author":"Dufe","year":"2007","journal-title":"J. Mol. Biol."},{"key":"2021112216002488500_B262","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jmb.2010.09.051","article-title":"The Clp chaperones and proteases of the human malaria parasite Plasmodium falciparum","volume":"404","author":"El Bakkouri","year":"2010","journal-title":"J. Mol. Biol."},{"key":"2021112216002488500_B263","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1074\/jbc.M112.416560","article-title":"Structural insights into the inactive subunit of the apicoplast-localized caseinolytic protease complex of Plasmodium falciparum","volume":"288","author":"El Bakkouri","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2021112216002488500_B264","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molbiopara.2011.06.001","article-title":"Characterization of a new phosphatase from Plasmodium","volume":"179","author":"Hills","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"2021112216002488500_B265","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/prot.22919","article-title":"Structures of parasitic CDPK domains point to a common mechanism of activation","volume":"79","author":"Wernimont","year":"2011","journal-title":"Proteins"},{"key":"2021112216002488500_B266","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jmb.2008.06.048","article-title":"Structures of substrate- and inhibitor-bound adenosine deaminase from a human malaria parasite show a dramatic conformational change and shed light on drug selectivity","volume":"381","author":"Larson","year":"2008","journal-title":"J. Mol. Biol."},{"key":"2021112216002488500_B267","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/1475-2875-12-187","article-title":"Designing the next generation of medicines for malaria control and eradication","volume":"12","author":"Burrows","year":"2013","journal-title":"Malar. J."},{"key":"2021112216002488500_B268","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1248\/yakushi.13-00001-3","article-title":"Structural biology for developing antimalarial compounds","volume":"133","author":"Tanaka","year":"2013","journal-title":"Yakugaku Zasshi"}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/461\/3\/349\/680947\/bj4610349.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/461\/3\/349\/680947\/bj4610349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T13:54:25Z","timestamp":1716990865000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/461\/3\/349\/46782\/From-crystal-to-compound-structure-based"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,10]]},"references-count":268,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20140240","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,10]]}}}